-
admin
Posts
2024 MWC Shanghai | H3C Fully Demonstrates New Achievements in Intelligent Computing, Accelerating the Construction of a New Intelligent Era
SHANGHAI, June 29, 2024 /PRNewswire/ — From June 26 to 28, 2024, the Mobile World Congress Shanghai (MWC Shanghai) grandly opened at the New International...
C40 Food Systems wins the Food Planet Prize, the $2-million environmental award, for shifting millions of meals in major cities to be healthier and more sustainable for people and the planet
STOCKHOLM, June 29, 2024 /PRNewswire/ — The Curt Bergfors Foundation is honored to announce that C40 Food Systems, a global network, was awarded the Food...
Japan Drugstore Market Analysis 2023-2024 & 2029: Trend Towards Shakeout and Restructuring, Growing Prescription Drugs Market, Expanding Product Offerings, Digitalization and Mechanization
Dublin, June 28, 2024 (GLOBE NEWSWIRE) — The “Japan Drugstore Market: Analysis By Product Category (Food, Household Utensils, Beauty Care, OTC Drugs, Dispensing, Health Care...
Global Weight Loss Supplement Market Size To Worth USD 101.83 Billion By 2033 | CAGR Of 13.52%
The Global Weight Loss Supplement Market Size was Valued at USD 28.65 Billion in 2023 and the Worldwide Weight Loss Supplement Market Size is Expected...
Eyenovia Announces Pricing of $5M Registered Direct Offering
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today that it has...
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency
– European Commission decision anticipated in the second half of 2024 – BOSTON, June 28, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a...
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
REDWOOD CITY, Calif., June 28, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle
SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes BOWIE, Md., June 28, 2024 (GLOBE NEWSWIRE) — Inovalon, a leading provider...
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on...
iQIYI Unveils Over 250 New Shows at 4th Annual Content Showcase in North America
Announcing Expansion in Brazil with More Portuguese Offerings BEIJING, June 28, 2024 /PRNewswire/ — On June 27, iQIYI, an innovative market-leading online entertainment service in...